Figure 3.
BRCA1 mutation carriers showed higher PAF-AH serum concentrations. PAF-AH serum concentrations were determined with ELISA. Higher levels of PAF-AH were detected in blood samples of BRCA1 mutation carriers (n = 6) when compared to patients with BRCA WT (n = 17) (Mann–Whitney U test, p = 0.012 indicated by asterisk *).
